Nepsilon-(Tert-Butoxycarbonyl)-Nalpha-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Lysine 98.0%(HPLC)
98.0%(HPLC)
Synonym: Fmoc-Lys(Boc)-OH
Linear Formula:
C26H32N2O6
Molecular Weight: 468.55g/mol
CAS Number: 71989-26-9
Properties
| Vapour pressure | 0.0±2.2 mmHg at 25℃ |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.566 |
| B pt. | 685.7℃ at 760 mmHg |
| M pt. | 124℃ |
| Density | 1.21 g/cm3 |
Safety Information
| Symbol | |
| HS Code | 2924299090 |
| Flash point | 368.5℃ |
| Storage Temp. | 2-8℃ |
| Packaging | Glass Bottle |
Description
Recommended products
O-Tert-Butyl-N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Serine 98.0%(HPLC)
Application
Fmoc-Lys(Boc)-OH can be used for The solid-phase synthesis of pentasubstituted dihydroimidazolylbutyl dihydroimidazol-3-ium salts by coupling with p-methylbenzhydrylamine (MBHA) resin. Fmoc-based peptide synthesis of bis-naphthalene diimide a threading intercalator. Synthesis of -Boc--(35-bis-trifluoromethyl-benzyl)--Fmoc-L-Lysine to be used as 19F NMR based screening tool.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Fmoc-Lys(Boc)-OH is used to prepare dimeric RGD peptide-paclitaxel conjugate as model for integrin-targeted drug delivery. It is also used to synthesize DOTA-conjugated multivalent cyclic-RGD peptide dendrimers for tumor targeting and imaging use.
Documents
|
COA Not Available |
|
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |